Clinical Trial Update: Testosterone Therapy in Castration Resistant Prostate Cancer [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating testosterone therapy in men with castration-resistant prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Prostate Cancer, Castration-Resistant Prostate Cancer | EARLY_Phase 1 | Status: COMPLETED